| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/ANNONC/MDT465 |
| P8608 | Fatcat ID | release_i5ghqncf7rfnpk7j6ccwvfj2mm |
| P698 | PubMed publication ID | 24265399 |
| P5875 | ResearchGate publication ID | 270815607 |
| P2093 | author name string | N. F. Hacker | |
| P2860 | cites work | Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment | Q85174042 |
| Global cancer statistics | Q22241238 | ||
| Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis | Q33957687 | ||
| Thirty-day mortality after primary cytoreductive surgery for advanced ovarian cancer in the elderly | Q35214119 | ||
| The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study | Q35611986 | ||
| Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes | Q37600225 | ||
| Neoadjuvant chemotherapy cannot be regarded as adequate routine therapy strategy of advanced ovarian cancer | Q37978470 | ||
| Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer | Q44461877 | ||
| Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study | Q45290500 | ||
| Prognostic significance of systematic lymphadenectomy as part of primary debulking surgery in patients with advanced ovarian cancer. | Q45971170 | ||
| Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies. | Q45973859 | ||
| Thoracoscopy for the management of advanced epithelial ovarian cancer--a preliminary report | Q46338207 | ||
| Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: a prospective study | Q46415035 | ||
| The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions | Q48860180 | ||
| The role of lymph node resection in ovarian cancer: analysis of the Surveillance, Epidemiology, and End Results (SEER) database. | Q53069039 | ||
| FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread. | Q53163950 | ||
| Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial | Q61900008 | ||
| Adjuvant chemotherapy | Q67316109 | ||
| Systematic pelvic and para-aortic lymphadenectomy during cytoreductive surgery in advanced ovarian cancer: potential benefit on survival | Q72130912 | ||
| The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery | Q72801655 | ||
| Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis | Q80019806 | ||
| A new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model | Q80549677 | ||
| Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon | Q81193468 | ||
| Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials | Q83092822 | ||
| Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarial | Q83287534 | ||
| Video-assisted thoracic surgery (VATS) evaluation of intrathoracic disease in patients with FIGO III and IV stage ovarian cancer | Q84185686 | ||
| Ten-year relative survival for epithelial ovarian cancer | Q84852379 | ||
| An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT) | Q84943384 | ||
| Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer | Q85006662 | ||
| Defining the limits of radical cytoreductive surgery for ovarian cancer | Q85014716 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | x27-32 | |
| P577 | publication date | 2013-12-01 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | State of the art of surgery in advanced epithelial ovarian cancer | |
| P478 | volume | 24 Suppl 10 |
Search more.